Unknown PHASE2 INTERVENTIONAL 2-arm NCT03521336

Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury

The Effect of Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells in Patients With Sub-Acute Spinal Cord Injury：A Multicenter, Randomized, Controlled Trial

Sponsor: Shanghai East Hospital

Conditions Spinal Cord Injury

Interventions Placebo Umbilical Cord Mesenchymal Stem Cells

Updated 7 times since 2018 Last updated: Apr 29, 2019 Started: Sep 1, 2019 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03521336, this PHASE2 trial focuses on Spinal Cord Injury and remains ongoing. Sponsored by Shanghai East Hospital, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting PHASE2
Jun 2019 — Jan 2021 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Jan 2019 — Jun 2019 [monthly]

Recruiting PHASE2
Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai East Hospital
Third Affiliated Hospital, Sun Yat-Sen University
West China Hospital

Data source: Third Affiliated Hospital, Sun Yat-Sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China